MassMutual Private Wealth & Trust FSB Trims Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• MassMutual Private Wealth & Trust FSB has reduced its stake in UnitedHealth Group by 56.0%, now holding 13,887 shares valued at approximately $4.33 million.
• UnitedHealth Group reported earnings of $4.08 per share in its latest quarter, missing analysts' expectations by $0.37, alongside revenue of $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, which results in an annualized dividend yield of 2.6%.

MassMutual Private Wealth & Trust FSB cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 56.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,887 shares of the healthcare conglomerate's stock after selling 17,655 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in UnitedHealth Group were worth $4,332,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd raised its stake in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Copia Wealth Management purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $42,000. Finally, Investment Management Corp VA ADV purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $44,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 2.4%

Shares of UNH opened at $339.57 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $307.54 billion, a P/E ratio of 14.71, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45. The stock's fifty day simple moving average is $293.51 and its 200 day simple moving average is $367.23. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UNH. Oppenheimer cut their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Finally, Wolfe Research dropped their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.